NDMA consumer survey reports high marks for OTC safety, convenience, value.
This article was originally published in The Rose Sheet
Executive Summary
OTC SAFETY, CONVENIENCE RECEIVE HIGH MARKS BY CONSUMERS in the first mailing of a consumer confidence tracking study conducted on behalf of the Nonprescription Drug Manufacturers Association. Speaking at NDMA's annual meeting in Colorado Springs on May 19, Sandoz Pharmaceuticals Director-Marketing, Research and Planning Mark Sanderson reported that 91% of 250 participating consumers agreed that "OTCs are safe" and 94% agreed that OTC drugs are "convenient to buy."